CII Gets New Leaders: Mukundan, Goenka, Ella to Drive Policy

ECONOMY
Whalesbook Logo
AuthorAarav Shah|Published at:
CII Gets New Leaders: Mukundan, Goenka, Ella to Drive Policy
Overview

The Confederation of Indian Industry (CII) has appointed R. Mukundan (Tata Chemicals) as President, Shashwat Goenka (RP-Sanjiv Goenka Group) as Vice President, and Suchitra K. Ella (Bharat Biotech) as President-Designate for 2026-27. This leadership team, spanning chemicals, diversified industries, and biotechnology, signals a strategic push to shape India's industrial policy in key growth areas.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Leadership Transition

The Confederation of Indian Industry (CII) has appointed R. Mukundan, Shashwat Goenka, and Suchitra K. Ella to lead its operations for the 2026-27 term. This new leadership brings together expertise from chemical manufacturing, diversified industrial groups, and biotechnology. This diverse background suggests they will aim to shape India's economic and industrial policy during a period of global economic change.

Leadership Roles and Sector Expertise

R. Mukundan, Managing Director and CEO of Tata Chemicals, will serve as President. With over 30 years in the chemical sector, including basic and specialty products, and education from IIT Roorkee and Harvard Business School, he is well-equipped to handle industrial challenges.

Shashwat Goenka, Vice Chairman of the RP-Sanjiv Goenka Group, takes on the Vice President role. He oversees diverse businesses in power, green energy, chemicals, retail, and IT. A Wharton alumnus and recognized Young Global Leader, Goenka has significant influence in new business trends.

Suchitra K. Ella, Co-founder and Managing Director of Bharat Biotech, will be President-Designate. Her leadership in biotechnology, especially vaccine development, and her Padma Bhushan award, highlight her contributions to healthcare and scientific innovation. This leadership team aims to align policies across core industries, advanced technology, and essential services.

Industry Outlook and Company Details

The Indian chemical industry is expected to grow significantly, with revenue projected to reach 18.31% of manufacturing value added by 2026. Government programs like 'Make in India' and Production Linked Incentive (PLI) schemes are boosting manufacturing competitiveness. Specialty chemicals are seeing increased demand from pharmaceuticals, electronics, and renewables, with India aiming for substantial export growth. Budget 2026's focus on chemical parks and MSME support further aids this trend.

In this environment, Tata Chemicals has a market capitalization around ₹19,411 Cr. Its trailing P/E ratio has fluctuated, recently around 111.5x to 126.67x in May 2026. While strong in soda ash and specialty products, the company has experienced poor sales growth over five years and a low return on equity. However, Morgan Stanley recently upgraded its stock to 'Overweight', citing recovery signs.

CESC Ltd., a key part of the RP-Sanjiv Goenka Group, has a market capitalization of approximately ₹24,125 Cr to ₹247.36 billion. Its P/E ratio is around 15.17x to 15.68x, and analysts generally hold an 'Overall Strong Buy' rating. CESC's integrated utility model serves over 3 million consumers and has shown decent sales and profit growth recently.

Overall, India's manufacturing sector is targeted to reach 25% of GDP by 2035, supported by policies and infrastructure development for global competitiveness. The proposed 'Made in India Brand Scheme' aims to enhance product quality and manufacturing competitiveness.

Potential Risks and Challenges

Despite broad industry representation from the new CII leadership, risks remain. The chemical sector faces volatility in input costs and global supply chain disruptions. Tata Chemicals, despite its market position, has shown poor sales growth and low return on equity, with P/E ratios often reflecting speculation rather than consistent earnings. The company has also contended with a low interest coverage ratio.

CESC operates within the utility sector, subject to significant regulatory oversight and potential policy changes impacting tariffs and operations. Although analysts largely rate it 'Strong Buy', Kotak previously downgraded it to 'Reduce', suggesting potential growth plan concerns. The RP-Sanjiv Goenka Group's diversification, while a strength, could also lead to diluted focus and mask weaknesses in individual businesses. CESC's high Debt/Equity ratio of 1.17 indicates a leveraged position, vulnerable during periods of rising interest rates or economic slowdown.

While the 'Made in India Brand Scheme' and PLI initiatives offer benefits, they may also increase competition and lead to overcapacity if not carefully managed. Reliance on government policy can create uncertainty if political or economic conditions change negatively.

Future Prospects

Analysts foresee significant growth in the chemical industry, positioning India as a major exporter. The Indian manufacturing sector is expected to continue receiving policy support and foreign direct investment, driven by PLI schemes and a focus on advanced manufacturing. The CII's new leadership is anticipated to address these trends, likely advocating for sustainable manufacturing, technology adoption, and export competitiveness. Government initiatives like the 'Made in India Brand Scheme' indicate a strong push to improve quality and global integration for Indian products.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.